DIMENSIONAL FUND ADVISORS LP

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in WHWK

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$103,810

+$34,500 QoQ

Shares Held

30,090

+5.1% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 44% Shared 21% None 35%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. WHWK ranks #197 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$103,810	30,090	+5.1%	Shares	Sole	2026-05-07
2025-12-31	$69,310	28,641	-35.1%	Shares	Sole	2026-02-12
2025-09-30	$83,818	44,115	-37.6%	Shares	Sole	2025-11-12
2025-06-30	$132,300	70,749	-34.2%	Shares	Sole	2025-08-12
2025-03-31	$191,384	107,520	+202.1%	Shares	Sole	2025-05-13
2024-12-31	$112,301	35,595	0.0%	Shares	Sole	2025-02-13
2024-09-30	$73,324	35,595	-0.2%	Shares	Sole	2024-11-07
2024-06-30	$52,057	35,656	+0.2%	Shares	Sole	2024-08-09
2024-03-31	$83,291	35,595	0.0%	Shares	Sole	2024-05-10
2023-12-31	$71,901	35,595	-30.6%	Shares	Sole	2024-02-07
2023-09-30	$248,073	51,255	-31.4%	Shares	Sole	2023-11-09
2023-06-30	$510,892	74,692	-16.4%	Shares	Sole	2023-08-09
2023-03-31	$646,544	89,302	+209.4%	Shares	Sole	2023-05-12
2022-12-31	$370,323	28,864	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.